Understanding the connection between mold illness, mycotoxins, and conditions like ME/CFS and MCAS is crucial for patients who have plateaued in their recovery
The ACC notes that clinicians should pay attention to gastrointestinal side effects, drug interactions, nutrition, and the patients overall cardiovascular situation when using GLP 1 therapies in practice
Space different supplements throughout the day and monitor for any interactions or amplified effects
Many people ask whether they can pause treatment after reaching their goal or use these medications temporarily rather than long-term
While most people can benefit from this pairing, certain groups will see the most significant impact
Monitor the regulatory timeline for retatrutide closely, as FDA approval in late 2026 would substantially change its availability for translational research applications